Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2003
09/17/2003EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
09/17/2003EP1343769A1 Benzoylpyridazines
09/17/2003EP1343768A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
09/17/2003EP1343764A1 Urea and urethane derivatives as integrin inhibitors
09/17/2003EP1343760A2 Muscarinic antagonists
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1343756A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343529A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
09/17/2003EP1343528A2 Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4
09/17/2003EP1343525A2 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE
09/17/2003EP1343522A2 Procollagen (iii) propeptides and related substances for treating fibrotic diseases
09/17/2003EP1343520A2 New therapeutic uses of smr1 peptides
09/17/2003EP1343519A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
09/17/2003EP1343516A2 Analogues of thiocoraline and be-22179
09/17/2003EP1343513A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
09/17/2003EP1343509A2 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
09/17/2003EP1343508A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343488A1 Treatment of statin side effects
09/17/2003EP1343487A2 Methods and compositions to treat conditions associated with neovascularization
09/17/2003EP1343486A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration
09/17/2003EP1343485A2 Lipid-based nitric oxide donors
09/17/2003EP1343483A2 Transdermal system containing a novel high potency progestagen
09/17/2003EP1343467A1 Composition containing 7-hydroxy dhea and/or 7-keto dhea and at least a carotenoid
09/17/2003EP1343465A2 Use of dna repair enzymes as mmp-1 inhibitors
09/17/2003EP1343434A1 Methods for contemporaneous administration of levamisole and 5-fluorouracil
09/17/2003EP1314426A9 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
09/17/2003EP1282622B1 Crf receptor antagonists and methods relating thereto
09/17/2003EP1244452B1 Carboxamide derivates of pyrrolidine and piperidine as urotensin-ii receptor antagonists
09/17/2003EP1230260B1 Hcv ns3 protease inhibitors
09/17/2003EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
09/17/2003EP1224166B1 Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
09/17/2003EP1169056B1 Caspase-8 inhibitors for immunosuppression.
09/17/2003EP1159295B1 Method of purifying whey of lactic acid fermentation by electrodialysis
09/17/2003EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
09/17/2003EP1117394B1 Use of carnitines and resveratrol to produce a composition for the prevention or therapeutic treatment of cerebral disorders brought about by ageing and use of neurotoxic drugs
09/17/2003EP1091734B1 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
09/17/2003EP1049697B1 Triazolo-pyridazine derivatives as ligands for gaba receptors
09/17/2003EP1042327B1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
09/17/2003EP1009755B1 Steroid sulfatase inhibitors and methods for making and using the same
09/17/2003EP0996446B1 Novel substituted imidazole compounds
09/17/2003EP0977737B1 Crf antagonistic quino- and quinazolines
09/17/2003EP0910566B1 Heterocyclic compounds and their preparation and use
09/17/2003EP0909184B1 Targeted drug delivery using sulfonamide derivatives
09/17/2003EP0891329B1 Peptidyl compounds having mmp and tnf inhibitory activity
09/17/2003EP0769940B1 INDENE sPLA2 INHIBITORS
09/17/2003EP0724647A4 Nucleic acid ligands and improved methods for producing the same
09/17/2003EP0657520B9 Antioxidant
09/17/2003CN1443199A Antibodies to human MCP-1
09/17/2003CN1443198A Ghrelin拮抗剂 Ghrelin Antagonist
09/17/2003CN1443197A Acid-modified arabinogalactan protein composition
09/17/2003CN1443190A Matrix metalloproteinase inhibitors
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443184A 嘧啶衍生物 Pyrimidine derivatives
09/17/2003CN1443178A (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphtyl] -4-morpholibenzamide
09/17/2003CN1443177A Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
09/17/2003CN1443176A Valsartan salts
09/17/2003CN1443173A Substituted imidazoles as TAFI a inhibitors
09/17/2003CN1443170A Capsaicin receptor ligands
09/17/2003CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443162A New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation
09/17/2003CN1443161A Aryl sulfonamides as serotonin antagonist for treatment of obesity
09/17/2003CN1443158A Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1443073A Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof
09/17/2003CN1443070A Apoptosis inhibiting composition comprising 15-keto-prostaglandin or derivative thereof
09/17/2003CN1443066A Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
09/17/2003CN1443065A Pharmaceutical composition improved in peroral absorbability
09/17/2003CN1443064A Administration of thiol-based chemoprotectant compound
09/17/2003CN1442195A Medicine for treating child multiacting disease and its preparation method
09/17/2003CN1442140A Use of substituted morphinan and its pharmaceutically acceptable salt in preparation of medicine for treating sustaining plant state
09/17/2003CN1442139A Medicinal composition for treating inflammation
09/17/2003CN1121403C Quinoxalinediones
09/17/2003CN1121391C Substituted 3-cyano quinolines
09/17/2003CN1121390C Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
09/17/2003CN1121389C Cyanoguanidines as cell proliferation inhibitors
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/17/2003CN1121374C Novel trienoic retinoid compounds and method
09/17/2003CN1121227C Veterinary medicine prepared from sophora seed and its preparing process
09/17/2003CN1121226C Chinese medicine for preventing and treating iatrogenic hypercortisonism
09/17/2003CN1121214C Use of alicyclic diamines as immunomodulators
09/16/2003US6620847 Copolymer-1 improvements in compositions of copolymers
09/16/2003US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
09/16/2003US6620832 Substituted ureas
09/16/2003US6620831 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
09/16/2003US6620828 Antiproliferative agents
09/16/2003US6620827 PPARγ modulators
09/16/2003US6620820 Inhibitors of bone reabsorption and antagonists of vitronectin receptors
09/16/2003US6620816 Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide
09/16/2003US6620811 Isonicotin- and nicotinamide derivatives of benzothiazoles
09/16/2003US6620810 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
09/16/2003US6620809 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine compounds
09/16/2003US6620806 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon
1 ... 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 ... 1564